Martha Leibl

Title: The Innovative Contributions of Inventor Martha Leibl

Introduction

Martha Leibl, based in Vienna, Austria, is an influential inventor in the field of immunology. With a focus on developing immunogenic constructs, his work has garnered attention due to its potential applications in vaccine development. With a total of one patent to his name, Leibl's contributions highlight the intersection of science and innovation in health-related technologies.

Latest Patents

Martha Leibl holds a notable patent for "Immunogenic constructs comprising flaviviruses or flavivirus derivatives." This invention revolves around an immunogenic construct that includes two key components: an inactive flavivirus or its derivative, and at least one immunogenic component that is either bonded to or adsorbed with the flavivirus. Additionally, the patent encompasses a process for preparing this immunogenic construct, reinforcing its significance as a potential vaccine.

Career Highlights

Leibl's professional journey is marked by significant contributions to the field of bio-engineering. He serves at Bio-Products & Bio-Engineering AG, where his research focuses on advancing immunological constructs. His innovative approach and commitment to vaccine development have made him a key figure in his field.

Collaborations

Martha Leibl collaborates with esteemed colleagues such as Josef Mannhalter and Heinz Leibl. Together, they push the boundaries of research in immunogenic constructs, sharing knowledge and resources to enhance the effectiveness of their innovations.

Conclusion

Martha Leibl's work exemplifies the vital role of inventors in developing solutions for contemporary health challenges. Through his patent concerning flavivirus derivatives, he continues to contribute significantly to the advancement of immunology and vaccine technology, demonstrating the profound impact that one inventor can have in protecting public health.